Free to attend
Learning outcomes
Delegates will understand:
- results from UK BPSU JSLE study
- JSLE diagnosis, investigation and management
- the impact of JSLE on patients
- the role of LUPUS UK.
Speakers
Professor Michael Beresford
Professor of Child Health, University of Liverpool, Honorary consultant paediatric rheumatologist, Alder Hey Children’s Hospital,
Director, UK Experimental Arthritis Treatment Centre for children,
Chair, Paediatric Committee, European Alliance of Associations for Rheumatology (EULAR)
Dr Hanna Lythgoe
Paediatric rheumatology trainee, Royal Manchester Children’s Hospital
Chief Investigator of JSLE BPSU study
Dr Eve Smith
NIHR academic clinical lecturer, University of Liverpool
Paediatric rheumatology consultant, Alder Hey Children’s Hospital
Sammy Ainsworth
Youth and Family Participation Officer, UK Experimental Arthritis Treatment Centre for Children
Trustee, LUPUS UK
Trustee, Raising Awareness of Invisible Illnesses in Schools and Education (RAIISE)
Board member, European Network for Children with Arthritis (ENCA)
Target audience
The target audience for this webinar is:
- General paediatricians
- Paediatric trainees
- Community paediatricians
- Allied health professionals
- Paediatric rheumatology CNS
- Paediatric nephrologists
- Paediatric neurologists
- Paediatric haematologists
- Paediatric endocrinologists
- GPs & GP trainees
- Public health doctors
- Pharmacists
It is also suitable for an international audience, with caveats on data (which is UK & Ireland) and treatment approaches which will be most relevant to the UK context
For more information
Please contact the RCPCH Education Team by email: education.provision@rcpch.ac.uk